BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

876 related articles for article (PubMed ID: 28741331)

  • 1. Alignment of adherence and risk for HIV acquisition in a demonstration project of pre-exposure prophylaxis among HIV serodiscordant couples in Kenya and Uganda: a prospective analysis of prevention-effective adherence.
    Haberer JE; Kidoguchi L; Heffron R; Mugo N; Bukusi E; Katabira E; Asiimwe S; Thomas KK; Celum C; Baeten JM
    J Int AIDS Soc; 2017 Jul; 20(1):21842. PubMed ID: 28741331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated Delivery of Antiretroviral Treatment and Pre-exposure Prophylaxis to HIV-1-Serodiscordant Couples: A Prospective Implementation Study in Kenya and Uganda.
    Baeten JM; Heffron R; Kidoguchi L; Mugo NR; Katabira E; Bukusi EA; Asiimwe S; Haberer JE; Morton J; Ngure K; Bulya N; Odoyo J; Tindimwebwa E; Hendrix C; Marzinke MA; Ware NC; Wyatt MA; Morrison S; Haugen H; Mujugira A; Donnell D; Celum C;
    PLoS Med; 2016 Aug; 13(8):e1002099. PubMed ID: 27552090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Counseling Framework for HIV-Serodiscordant Couples on the Integrated Use of Antiretroviral Therapy and Pre-exposure Prophylaxis for HIV Prevention.
    Morton JF; Celum C; Njoroge J; Nakyanzi A; Wakhungu I; Tindimwebwa E; Ongachi S; Sedah E; Okwero E; Ngure K; Odoyo J; Bulya N; Haberer JE; Baeten JM; Heffron R;
    J Acquir Immune Defic Syndr; 2017 Jan; 74 Suppl 1(Suppl 1):S15-S22. PubMed ID: 27930607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adherence to recommendations for ART and targeted PrEP use among HIV serodiscordant couples in East Africa: the "PrEP as a bridge to ART" strategy.
    Musinguzi N; Kidoguchi L; Mugo NR; Ngure K; Katabira E; Celum CL; Baeten JM; Heffron R; Haberer JE;
    BMC Public Health; 2020 Oct; 20(1):1621. PubMed ID: 33115478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brief Report: Context Matters: PrEP Adherence is Associated With Sexual Behavior Among HIV Serodiscordant Couples in East Africa.
    Haberer JE; Ngure K; Muwonge T; Mugo N; Katabira E; Heffron R; Musinguzi N; Bangsberg DR; Celum C; Baeten JM;
    J Acquir Immune Defic Syndr; 2017 Dec; 76(5):488-492. PubMed ID: 28961676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementation of a comprehensive safer conception intervention for HIV-serodiscordant couples in Kenya: uptake, use and effectiveness.
    Heffron R; Ngure K; Velloza J; Kiptinness C; Quame-Amalgo J; Oluch L; Thuo N; Njoroge J; Momanyi R; Gakuo S; Mbugua S; Morrison S; Haugen H; Chohan B; Celum C; Baeten JM; Mugo N
    J Int AIDS Soc; 2019 Apr; 22(4):e25261. PubMed ID: 30957420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sexual Behaviors After PrEP Discontinuation Among HIV Serodiscordant Couples in Kenya and Uganda.
    Stalter R; Mugwanya K; Thomas K; Donnell D; Mujugira A; Ngure K; Celum C; Kidoguchi L; Bukusi E; Baeten J; Heffron R;
    J Acquir Immune Defic Syndr; 2020 Oct; 85(2):174-181. PubMed ID: 32658130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beyond HIV prevention: everyday life priorities and demand for PrEP among Ugandan HIV serodiscordant couples.
    Nakku-Joloba E; Pisarski EE; Wyatt MA; Muwonge TR; Asiimwe S; Celum CL; Baeten JM; Katabira ET; Ware NC
    J Int AIDS Soc; 2019 Jan; 22(1):e25225. PubMed ID: 30657642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of pre-exposure prophylaxis targeted to high-risk serodiscordant couples as a bridge to sustained ART use in Kampala, Uganda.
    Ying R; Sharma M; Heffron R; Celum CL; Baeten JM; Katabira E; Bulya N; Barnabas RV
    J Int AIDS Soc; 2015; 18(4 Suppl 3):20013. PubMed ID: 26198348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brief Report: PrEP Use During Periods of HIV Risk Among East African Women in Serodiscordant Relationships.
    Pyra M; Haberer JE; Heffron R; Kidoguchi L; Brown ER; Bukusi EA; Asiimwe S; Celum C; Katabira E; Mugo NR; Baeten JM;
    J Acquir Immune Defic Syndr; 2018 Jan; 77(1):41-45. PubMed ID: 29016523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PrEP Discontinuation and Prevention-Effective Adherence: Experiences of PrEP Users in Ugandan HIV Serodiscordant Couples.
    Gilbert HN; Wyatt MA; Pisarski EE; Muwonge TR; Heffron R; Katabira ET; Celum CL; Baeten JM; Haberer JE; Ware NC
    J Acquir Immune Defic Syndr; 2019 Nov; 82(3):265-274. PubMed ID: 31609925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Since both of us are using antiretrovirals, we have been supportive to each other": facilitators and barriers of pre-exposure prophylaxis use in heterosexual HIV serodiscordant couples in Kisumu, Kenya.
    Patel RC; Stanford-Moore G; Odoyo J; Pyra M; Wakhungu I; Anand K; Bukusi EA; Baeten JM; Brown JM
    J Int AIDS Soc; 2016; 19(1):21134. PubMed ID: 27964776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No Evidence of Sexual Risk Compensation Following PrEP Initiation Among Heterosexual HIV Serodiscordant Couples in Kenya and Uganda.
    Ortblad KF; Stalter RM; Bukusi EA; Ngure K; Mujugura A; Celum C; Baeten JM; Heffron R
    AIDS Behav; 2020 May; 24(5):1365-1375. PubMed ID: 31696370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fertility Intentions, Pregnancy, and Use of PrEP and ART for Safer Conception Among East African HIV Serodiscordant Couples.
    Heffron R; Thomson K; Celum C; Haberer J; Ngure K; Mugo N; Bukusi E; Katabira E; Odoyo J; Bulya N; Asiimwe S; Tindimwebwa E; Baeten JM;
    AIDS Behav; 2018 Jun; 22(6):1758-1765. PubMed ID: 28894986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of a risk scoring tool to identify higher-risk HIV-1 serodiscordant couples for an antiretroviral-based HIV-1 prevention intervention.
    Irungu EM; Heffron R; Mugo N; Ngure K; Katabira E; Bulya N; Bukusi E; Odoyo J; Asiimwe S; Tindimwebwa E; Celum C; Baeten JM;
    BMC Infect Dis; 2016 Oct; 16(1):571. PubMed ID: 27751179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High medication adherence during periconception periods among HIV-1-uninfected women participating in a clinical trial of antiretroviral pre-exposure prophylaxis.
    Matthews LT; Heffron R; Mugo NR; Cohen CR; Hendrix CW; Celum C; Bangsberg DR; Baeten JM;
    J Acquir Immune Defic Syndr; 2014 Sep; 67(1):91-7. PubMed ID: 25118795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. I Knew I Would Be Safer. Experiences of Kenyan HIV Serodiscordant Couples Soon After Pre-Exposure Prophylaxis (PrEP) Initiation.
    Ngure K; Heffron R; Curran K; Vusha S; Ngutu M; Mugo N; Celum C; Baeten JM
    AIDS Patient Care STDS; 2016 Feb; 30(2):78-83. PubMed ID: 26836236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intimate Partner Violence and Self-Reported Pre-exposure Prophylaxis Interruptions Among HIV-Negative Partners in HIV Serodiscordant Couples in Kenya and Uganda.
    Cabral A; M Baeten J; Ngure K; Velloza J; Odoyo J; E Haberer J; Celum C; Muwonge T; Asiimwe S; Heffron R;
    J Acquir Immune Defic Syndr; 2018 Feb; 77(2):154-159. PubMed ID: 29076883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adherence to antiretroviral prophylaxis for HIV prevention: a substudy cohort within a clinical trial of serodiscordant couples in East Africa.
    Haberer JE; Baeten JM; Campbell J; Wangisi J; Katabira E; Ronald A; Tumwesigye E; Psaros C; Safren SA; Ware NC; Thomas KK; Donnell D; Krows M; Kidoguchi L; Celum C; Bangsberg DR
    PLoS Med; 2013; 10(9):e1001511. PubMed ID: 24058300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depression and ART Initiation Among HIV Serodiscordant Couples in Kenya and Uganda.
    Velloza J; Celum C; Haberer JE; Ngure K; Irungu E; Mugo N; Baeten JM; Heffron R;
    AIDS Behav; 2017 Aug; 21(8):2509-2518. PubMed ID: 28634661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.